Experimental Whole-Virus Flu Vaccine Shows Safety and Broad Immune Signals in First Human Trial
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
Tag: BPL-1357
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era